XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash Flows from Operating Activities    
Net income available to common stockholders $ 91,183 $ 91,099
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 20,237 20,574
Stock compensation expense 8,686 7,257
Exit activity costs, non-cash 163 572
(Benefit of) provision for deferred income taxes (615) 179
Other, net 4,160 2,945
Changes in operating assets and liabilities net of effects from acquisitions:    
Trade receivables and costs in excess of billings (23,995) (44,331)
Inventories (18,131) 30,431
Other current assets and other assets (11,781) (1,426)
Accounts payable 70,867 53,198
Accrued expenses and other non-current liabilities 13,561 46,158
Net cash provided by operating activities 154,335 206,656
Cash Flows from Investing Activities    
Purchases of property, plant, and equipment, net (14,326) (7,976)
Acquisitions, net of cash acquired 0 (9,863)
Net proceeds from sale of business 350 0
Net cash used in investing activities (13,976) (17,839)
Cash Flows from Financing Activities    
Proceeds from long-term debt 0 50,000
Long-term debt payments 0 (141,000)
Purchase of common stock at market prices (10,940) (29,182)
Net cash used in financing activities (10,940) (120,182)
Effect of exchange rate changes on cash 34 (778)
Net increase in cash and cash equivalents 129,453 67,857
Cash and cash equivalents at beginning of year 99,426 17,608
Cash and cash equivalents at end of period $ 228,879 $ 85,465